Abstract
We report the case of a patient who developed Graves’ disease and a papillary thyroid cancer only 5 years after irradiation and adjuvant chemotherapy for Hodgkin’s disease. This case is peculiar for the very short latency time between Hodgkin’s disease treatment and thyroid cancer development, an event possibly related to Graves’ disease with elevated serum levels of TSAb. We conclude that, in patients treated for Hodgkin’s disease, continued follow-up by clinical examination and sonography of the thyroid is needed, especially if they develop Graves’ disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nelson D.F., Reddy K.V., O’Mara R.E., Rubin P. Thyroid abnormalities following neck irradiation for Hodgkin’s disease. Cancer 42: 2553, 1978.
Hancock S.L., Cox R., McDougall I.R. Thyroid diseases after treatment of Hodgkin’s disease. N. Engl. J. Med. 325: 599, 1991.
Kaldor J.M., Day N.E., Band P., Choi N.W., Clarke E.A., Coleman M.P., Hakama M., Koch M., Langmark F., Neal F.E. Second malignancies following testicular cancer, ovarian cancer, and Hodgkin’s disease: an international collaborative study among cancer registries. Int. J. Cancer 39: 571, 1987.
Tucker M.A., Coleman C.N., Cox R.S., Varghese A., Rosemberg S.A. Risk of second cancers after treatment for Hodgkin’s disease. N. Engl. J. Med. 318: 76, 1988.
Santoro A., Bonadonna G., Bonfante V., Valagussa P. Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N. Engl. J. Med. 306: 770, 1982.
Belfiore A., Garofalo M.R., Giuffrida D., Runello F., Filetti S., Fiumara A., Ippolito O., Vigneri R. Increased aggressiveness of thyroid cancer in patients with Graves’ disease. J. Clin. Endocrinol. Metab. 70: 830, 1990.
Farbota L.M., Calandra D.B., Lawrence A.M., Paloyan E. Thyroid carcinoma in Graves’ disease. Surgery 98: 1148, 1985.
Mazzaferri E.L. Thyroid cancer and Graves’ disease. J. Clin. Endocrinol. Metab. 70: 826, 1990.
Farid N.R., Shi Y., Zou M. Molecular basis of thyroid cancer. Endocr. Rev. 15: 202, 1994.
Hales I.B., McElduff A., Crummer P., Clifton-Bligh P., Delbridge L., Hoschl R., Pole A., Reeve T.S., Wilmshurst E., Wiseman J. Does Graves’ disease or thyrotoxicosis affect the prognosis of thyroid cancer. J. Clin. Endocrinol. Metab. 75: 886, 1992.
Filetti S., Belfiore A., Amir S.M., Daniels G.H., Ippolito O., Vigneri R., Ingbar S. The role of thyroid-stimulating antibodies of Graves’ disease in differentiated thyroid cancer. N. Engl. J. Med. 318: 753, 1988.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Belfiore, A., Pellegriti, G., Milone, G. et al. Early occurrence of a thyroid carcinoma in a patient who developed Graves’ disease after treatment for Hodgkin’s disease. J Endocrinol Invest 18, 869–871 (1995). https://doi.org/10.1007/BF03349835
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349835